- Home
- AMCI vs FATE Comparison
AMCI vs FATE Comparison
Compare AMCI & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMCI | FATE |
|---|---|---|
| Founded | 2021 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.0M | 139.6M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | AMCI | FATE |
|---|---|---|
| Price | $7.14 | $1.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.10 |
| AVG Volume (30 Days) | 50.6K | ★ 1.5M |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.88 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $6,646,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.05 |
| P/E Ratio | $33.37 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.60 | $0.66 |
| 52 Week High | $15.75 | $1.94 |
Technical Indicators
Market Signals| Indicator | AMCI | FATE |
|---|---|---|
| Relative Strength Index (RSI) | 56.48 | 48.03 |
| Support Level | $5.84 | $0.96 |
| Resistance Level | $7.75 | $1.35 |
| Average True Range (ATR) | 0.66 | 0.13 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 74.62 | 10.32 |
Price Performance
Historical ComparisonAbout AMCI AMC Robotics Corporation Common Stock
AMC Robotics Corp is an artificial intelligence services company that develops robotic solutions designed to support operational efficiency across sectors such as logistics and manufacturing. The company develops robotics and automation technologies designed to improve logistics operations. Its robots use sensors and visual AI to support real-time decision-making, contributing to safer and more efficient warehouse operations. It builds autonomous robots for use in logistics and warehousing.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.